GENERAL18 Sept 2026
CDSCO forms expert panel to regulate AI use in drug discovery: DCGI
India's drug regulator CDSCO has formed an expert panel to decide how artificial intelligence (AI) is used in drug discovery. DCGI Rajeev Raghuvanshi says the panel includes AI experts. It will discuss how AI used in drug discovery should be evaluated, approved and regulated. So companies using AI in research will want to follow how these checks are framed.
Key Statutory Highlights
- CDSCO has set up an expert panel to look at how AI is used in drug discovery.
- DCGI Rajeev Raghuvanshi said the panel includes AI experts.
- The panel will discuss how AI used in drug discovery should be evaluated, approved and regulated.
Actionable Advice for Taxpayers / Founders:If your company uses AI in drug research, keep a watch on CDSCO's guidance as it comes and check with your regulatory consultant before treating any AI-based method as approved.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: